Tomic, Radovan, Health Economics Specialist, Novartis Farma S.p.A., Italy

• Vol 13, No 1 (2012) - Original research
  Clinical and economic impact of aliskiren in uncontrolled hypertensive patients
  Abstract  HTML  PDF